CA Patent

CA2507266A1 — Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

Assigned to Boehringer Ingelheim International GmbH · Expires 2004-06-10 · 22y expired

What this patent protects

The invention relates to a novel pharmaceutical combination for the treatmen t of bladder dysfunction, said combination comprising a serotonin and/or norepinephrine reuptake inhibitor and a beta-3-adrenoceptor agonist.

USPTO Abstract

The invention relates to a novel pharmaceutical combination for the treatmen t of bladder dysfunction, said combination comprising a serotonin and/or norepinephrine reuptake inhibitor and a beta-3-adrenoceptor agonist.

Drugs covered by this patent

Patent Metadata

Patent number
CA2507266A1
Jurisdiction
CA
Classification
—
Expires
2004-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.